In a further step we refined the cohort and only included patients with primary, unifocal, unilateral breast cancer that are not older than 70 years at diagnosis with tumors that are estrogen receptor-positive, Her2-negative and of no special type (NST), as these factors represent the majority of breast cancer characteristics in our cohort. Here, ERBB2 is linked to breast carcinoma.